Bizelesin

CAS : 129655-21-6

Ref. 3D-BB181412

Informations sur le produit

• Nom: Bizelesin
• Synonymes: Bizelesin [USAN:INN], 1,3-Bis(2-(((S)-1-(chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)indol-5-yl)urea, Benzo(1,2-b:4,3-b')dipyrrol-4-ol, 6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*))-, U-77,779, Unii-L0O9Obi87E, 1,3-bis(2-{[(1S)-1-(chloromethyl)-5-hydroxy-8-methyl-1,6-dihydropyrrolo[3,2-e]indol-3(2H)-yl]carbonyl}-1H-indol-5-yl)urea, 1-(2-{[(1S)-1-(chloromethyl)-5-hydroxy-8-methyl-1,6-dihydropyrrolo[3,2-e]indol-3(2H)-yl]carbonyl}-1H-indol-5-yl)-3-(2-{[1-(chloromethyl)-5-hydroxy-8-methyl-1,6-dihydropyrrolo[3,2-e]indol-3(2H)-yl]carbonyl}-1H-indol-5-yl)urea
• CAS: 129655-21-6

Description

Bizelesin is a benzoic acid derivative that has surfactant properties. It has been shown to have anti-cancer activity, specifically against breast and ovarian cancer cells. Bizelesin works by binding to DNA and inhibiting the transcription of genes involved in cell proliferation. This drug can also inhibit c-Met, a receptor tyrosine kinase that is involved in cell growth and survival. Bizelesin can be extracted from natural sources or synthesized chemically. It has been immobilized onto various surfaces, including magnetic nanoparticles and silica gel, for use in drug delivery systems. Additionally, bizelesin has been used as a substrate for enzymes such as amidase and acylase, which can convert it into other compounds with potential therapeutic applications.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 815.7 g/mol
• Formule: C₄₃H₃₆Cl₂N₈O₅
• Degré de pureté: Min. 95%